ICL Operating Income vs Other Operating Expenses Analysis

ICL Stock

USD 4.72 0.05 1.05%

ICL Israel financial indicator trend analysis is infinitely more than just investigating ICL Israel Chemicals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICL Israel Chemicals is a good investment. Please check the relationship between ICL Israel Operating Income and its Other Operating Expenses accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Operating Income vs Other Operating Expenses

Operating Income vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICL Israel Chemicals Operating Income account and Other Operating Expenses. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between ICL Israel's Operating Income and Other Operating Expenses is 0.54. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of ICL Israel Chemicals, assuming nothing else is changed. The correlation between historical values of ICL Israel's Operating Income and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of ICL Israel Chemicals are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Operating Income i.e., ICL Israel's Operating Income and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.54

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Operating Income

Operating Income is the amount of profit realized from ICL Israel Chemicals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of ICL Israel Chemicals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of ICL Israel Chemicals. It is also known as ICL Israel overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most indicators from ICL Israel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICL Israel Chemicals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Sales General And Administrative To Revenue is expected to rise to 0.08 this year, although the value of Selling General Administrative will most likely fall to about 379.1 M.

	2021	2022	2023	2024 (projected)
Interest Expense	216M	327M	176.7M	120.4M
Depreciation And Amortization	588M	713M	590.1M	371.6M

Interest Expense Depreciation And Amortization

ICL Israel fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.7	0.61	0.95	0.92	0.93	0.55	0.77	0.95	0.56	0.96	0.41	0.64	0.88	0.96	0.45	0.4	0.34	0.76	0.86	0.42	0.09	0.89	0.64	0.85	0.56
Short Long Term Debt Total	0.7		0.59	0.69	0.36	0.66	0.98	0.3	0.61	0.03	0.77	0.37	0.06	0.48	0.69	0.12	0.24	-0.1	0.97	0.44	0.13	-0.06	0.94	0.24	0.4	0.57
Other Current Liab	0.61	0.59		0.58	0.45	0.75	0.54	0.43	0.51	0.21	0.68	-0.21	0.15	0.4	0.67	0.24	0.14	-0.25	0.6	0.35	0.46	0.66	0.64	0.61	0.33	0.23
Total Current Liabilities	0.95	0.69	0.58		0.84	0.85	0.54	0.71	0.95	0.59	0.89	0.37	0.66	0.86	0.95	0.46	0.39	0.35	0.71	0.83	0.39	0.07	0.88	0.65	0.85	0.69
Total Stockholder Equity	0.92	0.36	0.45	0.84		0.85	0.19	0.84	0.88	0.68	0.83	0.31	0.77	0.86	0.86	0.56	0.38	0.52	0.44	0.88	0.46	0.13	0.63	0.69	0.88	0.45
Property Plant And Equipment Net	0.93	0.66	0.75	0.85	0.85		0.55	0.73	0.84	0.39	0.98	0.26	0.44	0.68	0.88	0.45	0.33	0.15	0.71	0.67	0.35	0.36	0.82	0.65	0.64	0.54
Net Debt	0.55	0.98	0.54	0.54	0.19	0.55		0.16	0.45	-0.17	0.67	0.32	-0.16	0.29	0.54	0.03	0.18	-0.22	0.93	0.27	0.04	-0.06	0.85	0.09	0.2	0.53
Retained Earnings	0.77	0.3	0.43	0.71	0.84	0.73	0.16		0.74	0.77	0.7	0.25	0.65	0.71	0.71	0.73	0.8	0.5	0.37	0.74	0.38	0.29	0.53	0.89	0.73	0.36
Accounts Payable	0.95	0.61	0.51	0.95	0.88	0.84	0.45	0.74		0.65	0.88	0.46	0.71	0.91	0.93	0.36	0.4	0.35	0.68	0.86	0.41	0.06	0.84	0.65	0.88	0.5
Cash	0.56	0.03	0.21	0.59	0.68	0.39	-0.17	0.77	0.65		0.37	0.17	0.91	0.76	0.59	0.57	0.6	0.59	0.11	0.69	0.34	0.13	0.31	0.8	0.79	0.12
Non Current Assets Total	0.96	0.77	0.68	0.89	0.83	0.98	0.67	0.7	0.88	0.37		0.38	0.43	0.72	0.91	0.42	0.35	0.18	0.82	0.71	0.3	0.2	0.91	0.58	0.67	0.6
Non Currrent Assets Other	0.41	0.37	-0.21	0.37	0.31	0.26	0.32	0.25	0.46	0.17	0.38		0.31	0.38	0.28	0.02	0.27	0.47	0.45	0.39	-0.11	-0.52	0.45	-0.08	0.37	0.3
Cash And Short Term Investments	0.64	0.06	0.15	0.66	0.77	0.44	-0.16	0.65	0.71	0.91	0.43	0.31		0.84	0.65	0.49	0.33	0.72	0.14	0.77	0.32	-0.07	0.36	0.62	0.88	0.22
Net Receivables	0.88	0.48	0.4	0.86	0.86	0.68	0.29	0.71	0.91	0.76	0.72	0.38	0.84		0.87	0.34	0.39	0.47	0.57	0.94	0.52	-0.11	0.73	0.62	0.98	0.32
Good Will	0.96	0.69	0.67	0.95	0.86	0.88	0.54	0.71	0.93	0.59	0.91	0.28	0.65	0.87		0.49	0.34	0.26	0.73	0.84	0.43	0.16	0.87	0.69	0.84	0.53
Common Stock Total Equity	0.45	0.12	0.24	0.46	0.56	0.45	0.03	0.73	0.36	0.57	0.42	0.02	0.49	0.34	0.49		0.61	0.57	0.08	0.37	-0.05	0.29	0.23	0.72	0.42	0.48
Common Stock Shares Outstanding	0.4	0.24	0.14	0.39	0.38	0.33	0.18	0.8	0.4	0.6	0.35	0.27	0.33	0.39	0.34	0.61		0.41	0.28	0.4	0.08	0.12	0.35	0.69	0.4	0.23
Short Term Investments	0.34	-0.1	-0.25	0.35	0.52	0.15	-0.22	0.5	0.35	0.59	0.18	0.47	0.72	0.47	0.26	0.57	0.41		-0.07	0.49	-0.05	-0.38	0.09	0.29	0.59	0.33
Non Current Liabilities Total	0.76	0.97	0.6	0.71	0.44	0.71	0.93	0.37	0.68	0.11	0.82	0.45	0.14	0.57	0.73	0.08	0.28	-0.07		0.51	0.18	-0.07	0.96	0.27	0.47	0.46
Inventory	0.86	0.44	0.35	0.83	0.88	0.67	0.27	0.74	0.86	0.69	0.71	0.39	0.77	0.94	0.84	0.37	0.4	0.49	0.51		0.64	-0.13	0.68	0.59	0.97	0.36
Other Current Assets	0.42	0.13	0.46	0.39	0.46	0.35	0.04	0.38	0.41	0.34	0.3	-0.11	0.32	0.52	0.43	-0.05	0.08	-0.05	0.18	0.64		0.25	0.28	0.41	0.54	-0.11
Other Stockholder Equity	0.09	-0.06	0.66	0.07	0.13	0.36	-0.06	0.29	0.06	0.13	0.2	-0.52	-0.07	-0.11	0.16	0.29	0.12	-0.38	-0.07	-0.13	0.25		-0.02	0.58	-0.15	-0.1
Total Liab	0.89	0.94	0.64	0.88	0.63	0.82	0.85	0.53	0.84	0.31	0.91	0.45	0.36	0.73	0.87	0.23	0.35	0.09	0.96	0.68	0.28	-0.02		0.44	0.65	0.58
Property Plant And Equipment Gross	0.64	0.24	0.61	0.65	0.69	0.65	0.09	0.89	0.65	0.8	0.58	-0.08	0.62	0.62	0.69	0.72	0.69	0.29	0.27	0.59	0.41	0.58	0.44		0.62	0.24
Total Current Assets	0.85	0.4	0.33	0.85	0.88	0.64	0.2	0.73	0.88	0.79	0.67	0.37	0.88	0.98	0.84	0.42	0.4	0.59	0.47	0.97	0.54	-0.15	0.65	0.62		0.37
Short Term Debt	0.56	0.57	0.23	0.69	0.45	0.54	0.53	0.36	0.5	0.12	0.6	0.3	0.22	0.32	0.53	0.48	0.23	0.33	0.46	0.36	-0.11	-0.1	0.58	0.24	0.37

Click cells to compare fundamentals

ICL Israel Account Relationship Matchups

ICL Israel fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.2B	9.7B	11.1B	11.8B	11.5B	7.7B
Short Long Term Debt Total	2.6B	2.8B	3.0B	2.8B	2.7B	2.2B
Other Current Liab	587M	741M	938M	1.0B	844.0M	531.1M
Total Current Liabilities	1.8B	2.2B	2.6B	2.6B	2.6B	1.9B
Total Stockholder Equity	3.9B	3.9B	4.5B	5.5B	5.7B	3.1B
Property Plant And Equipment Net	5.2B	5.6B	5.8B	6.0B	6.3B	3.7B
Net Debt	2.5B	2.6B	2.5B	2.4B	2.2B	2.0B
Retained Earnings	3.9B	3.8B	4.3B	5.4B	5.5B	5.8B
Accounts Payable	712M	735M	1.1B	1.0B	904.5M	633.2M
Cash	95M	214M	473M	417M	416.5M	437.4M
Non Current Assets Total	6.5B	6.8B	7.2B	7.2B	7.5B	4.8B
Non Currrent Assets Other	353M	393M	279.8M	228M	217.9M	228.4M
Cash And Short Term Investments	191M	314M	564M	508M	587.1M	325.4M
Net Receivables	1.2B	1.3B	1.8B	1.9B	1.6B	1.2B
Good Will	302M	320M	502M	507M	525.6M	266.1M
Common Stock Shares Outstanding	1.3B	1.3B	1.3B	1.3B	1.3B	1.4B
Short Term Investments	92M	96M	100M	91M	170.6M	127.4M
Liabilities And Stockholders Equity	9.2B	9.7B	11.1B	11.8B	11.5B	7.7B
Non Current Liabilities Total	3.4B	3.4B	3.7B	3.4B	2.9B	2.6B
Inventory	1.3B	1.3B	1.6B	2.1B	1.7B	1.3B
Other Current Assets	51M	50M	115.2M	4.0B	121.0M	114.9M
Other Stockholder Equity	(62M)	(56M)	(36M)	(27M)	(25.8M)	(24.5M)
Total Liab	5.1B	5.6B	6.3B	6.0B	5.5B	4.5B
Property Plant And Equipment Gross	5.3B	5.6B	12.5B	13.0B	13.8B	14.5B
Total Current Assets	2.7B	2.8B	3.9B	4.5B	4.0B	2.9B
Accumulated Other Comprehensive Income	(439M)	(312M)	(306M)	(443M)	(335.2M)	(352.0M)
Short Term Debt	420M	684M	577M	512M	850.9M	537.1M
Current Deferred Revenue	42M	17M	33M	41M	16.9M	16.0M
Intangible Assets	332M	336M	365M	345M	343M	403.7M
Other Liab	1.2B	1.3B	1.3B	1.1B	1.3B	1.1B
Other Assets	362M	309M	378M	524M	434.7M	384.2M
Long Term Debt	2.2B	2.1B	2.4B	2.3B	1.6B	2.3B
Property Plant Equipment	5.3B	5.6B	5.8B	6.0B	6.9B	5.1B
Net Tangible Assets	3.3B	3.3B	3.7B	4.6B	5.3B	3.1B
Long Term Investments	140M	83M	26M	3M	2M	1.9M
Short Long Term Debt	371M	684M	577M	512M	786M	523.7M
Long Term Debt Total	1.8B	2.2B	2.1B	2.4B	2.2B	1.9B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:

How To Invest In ICL

Details

Is ICL Stock a good investment?

Details

What is ICL Israel's Net Worth?

Details

Largest Agricultural Inputs Companies

View

Largest Basic Materials Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICL Israel Chemicals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Note that the ICL Israel Chemicals information on this page should be used as a complementary analysis to other ICL Israel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for ICL Stock analysis

When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.

	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	CEOs Directory Screen CEOs from public companies around the world
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Is ICL Israel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.63)

Dividend Share

0.214

Earnings Share

0.36

Revenue Per Share

5.549

Quarterly Revenue Growth

(0.18)

The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ICL Operating Income vs Other Operating Expenses Analysis

Operating Income vs Other Operating Expenses

Operating Income vs Other Operating Expenses Correlation Analysis

Correlation Coefficient

Operating Income

Other Operating Expenses

ICL Israel fundamental ratios Correlations

ICL Israel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

ICL Israel fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for ICL Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 0.98	Short Long Term Debt Total
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net
Total Current Assets	+ 0.98	Net Receivables
Non Current Liabilities Total	+ 0.97	Short Long Term Debt Total
Total Current Assets	+ 0.97	Inventory
Non Current Assets Total	+ 0.96	Total Assets

Other Stockholder Equity	- 0.52	Non Currrent Assets Other
Other Stockholder Equity	- 0.38	Short Term Investments
Short Term Investments	- 0.25	Other Current Liab
Short Term Investments	- 0.22	Net Debt
Non Currrent Assets Other	- 0.21	Other Current Liab
Cash	- 0.17	Net Debt